Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BAYER HLTHCARE

  • FDA Approval
  • Nov. 21, 2023, 16:25 UTC
  • 32
  • 0 comments

FDA approve AZELASTINE HYDROCHLORIDE

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 32
  • 0 comments

FDA approve TEMAZEPAM

Comment Full text

EUGIA PHARMA SPECLTS

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 28
  • 0 comments

FDA approve CYCLOPHOSPHAMIDE

Comment Full text

LUPIN LTD

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 26
  • 0 comments

FDA approve PITAVASTATIN CALCIUM

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 31
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

AMNEAL

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 28
  • 0 comments

FDA approve ESTRADIOL

Comment Full text

AUROBINDO PHARMA USA

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 30
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

SUN PHARM

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 34
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

DEXCEL

  • FDA Approval
  • Nov. 21, 2023, 09:39 UTC
  • 31
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

BOEHRINGER INGELHEIM

  • FDA Approval
  • Nov. 20, 2023, 09:44 UTC
  • 37
  • 0 comments

FDA approve DABIGATRAN ETEXILATE MESYLATE

Comment Full text
  • Previous
  • 632
  • 633
  • 634
  • 635
  • 636
  • Next

Search

News categories

  • Technical Exchange News(11963)
  • Event(4938)
  • SEC News(246241)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(148402)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin